Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Adductor Canal Block for Pain After Knee Replacement
NCT06382285Not yet recruiting
- Sponsor
- Shamir Medical Center
- Start
- Oct 2024
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Shamir Medical Center. Primary endpoints: Pain level and Analgesic use. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06382285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06382285.